The Quality of Pap Smears from the Brazilian Cervical Cancer Screening Program According to the Human Development Index
- 1 March 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 13 (3) , 299-308
Abstract
Brazil is a country with strong socioeconomic disparities, which may explain the different rates of cervical cancer incidence and mortality and influence the quality of cervical cancer screening tests. The aim of this study was to perform a trend analysis of some quality indicators of Pap smears according to the Municipal Human Development Index (MHDI). Information about cytopathological exams (approximately 65,000,000) performed from 2006 to 2014 in women aged 25-64 years was obtained from the Cervical Cancer Information System (SISCOLO). The average annual percentage change (AAPC) for each indicator was calculated using the Joinpoint Regression Program, according to MHDI levels. Very low frequencies of unsatisfactory cases (<5%) were observed at different MHDI levels. Although the positivity index in the low- and medium-MHDI groups has increased, the values remained below international recommendations (3-10%). The HSIL (high-grade squamous intraepithelial lesion) percentage remained stationary at all levels of the MHDI. In the low- and medium-MHDI groups, most quality indicators were below the recommendations by Brazilian National Cancer Institute INCA, with no improvement trend; in the high-MHDI group, the majority of the indicators also presented no improvement, although they show slightly better quality indicators. The MHDI should be considered in the definition of the policies of the screening program for cervical cancer in Brazil, and the current program may require adjustments to achieve improved efficiency.Keywords
All Related Versions
Funding Information
- Barretos Cancer Hospital
This publication has 25 references indexed in Scilit:
- Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regionsThe Lancet, 2012
- Monitoramento externo da qualidade dos exames citopatológicos cervicais realizados pelo Sistema Único de Saúde (SUS) no Estado de Mato Grosso do SulRevista Brasileira de Ginecologia e Obstetrícia, 2012
- Global cancer transitions according to the Human Development Index (2008–2030): a population-based studyThe Lancet Oncology, 2012
- Influência da adequabilidade da amostra sobre a detecção das lesões precursoras do câncer cervicalRevista Brasileira de Ginecologia e Obstetrícia, 2008
- Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort studyBMJ, 2008
- A revisão rápida de 100% é eficiente na detecção de resultados falsos-negativos dos exames citopatológicos cervicais e varia com a adequabilidade da amostra: uma experiência no BrasilRevista Brasileira de Ginecologia e Obstetrícia, 2007
- Integration of human papillomavirus vaccination, cytology, and human papillomavirus testingCancer, 2007
- Perfil dos laboratórios de citopatologia do Sistema Único de SaúdeJornal Brasileiro de Patologia e Medicina Laboratorial, 2007
- Fatores associados a resultados falso-negativos de exames citopatológicos do colo uterinoRevista Brasileira de Ginecologia e Obstetrícia, 2006
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003